Seles’ first symptoms appeared suddenly around three years ago. She began having double vision and weakness in her arms and ...
In D.C., which has one of the nation’s highest dementia rates, health advocates are pushing for earlier detection and ...
Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the first Phase III (FENhance 2) of ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will outline the next chapter of its evolution today during an ...
A 25-year-old man developed sudden vision problems, memory loss, and difficulty walking just weeks after undergoing bariatric surgery. Dr. Sudhir Kumar, a senior neurologist at Apollo Hospitals, ...
The Nasdaq 100 enjoyed one of those well-timed Friday afternoon rallies (1.9% off morning trading lows) to somewhat ease ...